SRTA Blade Air Mobility: Debt to Equity

Strata Critical Medical Inc - graphic logo of issuer SRTA

Strata Critical Medical Inc (SRTA) relies on the solvent demand of major hospitals and transplant centers, generating revenue from the urgent transport of organs and physicians. Pricing power is constrained by a decline in charter spending among high-net-worth clients, although emergency transport remains price-insensitive. The market trend for SRTA shares, with a debt-to-equity ratio of 0.02, reflects the performance of the aviation logistics operator within the critical medical segment.

SRTA: blade.com Debt to Capital 07/04/2022 - 10/29/2026
Finished products of Strata Medical

The investment attractiveness of Strata Critical Medical Inc (SRTA) depends on the balance between aggressive growth and financial stability. This metric compares total liabilities with equity to determine the business's degree of dependence on creditors. By analyzing the company's leverage through the debt-to-equity ratio, an investor assesses the risk of default. For Strata Critical Medical Inc (SRTA), this is critical when financing the recruitment of scarce aviation specialists. An optimal proportion confirms the capital's ability to support operational expansion.

Key competitors

Debt to Equity Boston Scientific Corporation|Edwards (EW) - Total Debt to Capital Coefficient|Debt to Equity ResMed Corp (RMD)|PODD: Aggregate Debt to Equity|Total Debt to Capital ZBH (Zimmer Biomet Corp)|coopercos.com (COO) - Debt to Capital|Align Technology - Total Debt to Capital|Globus Medical Inc (GMED) - Total Debt to Equity Ratio|TMDX: Total Debt to Capital|ATEC - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital enovis.com|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity ESTA (Establishment Labs Corp)|Total Debt to Capital BBNX (Beta Bionics Corp)|Total Debt to Capital Coefficient IRADIMED Inc. (IRMD)|EMBC: Total Debt to Equity Ratio|Aggregate Debt to Equity TNDM|AXGN: Total Debt to Capital|Debt to Capital SI-BONE Inc (SIBN)|OFIX (Orthofix International) - Total Debt to Capital|Debt to Equity Ratio BVS (Bioventus Global)|Total Debt to Equity Ratio KIDS (OrthoPediatrics Corp.)|TMCI (treace.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Carlsmed CARL|RXST - Total Debt to Equity Ratio|ClearPoint - Total Debt to Capital|Debt to Capital Stereotaxis Corporation|STIM: Total Debt to Capital|Debt to Equity Ratio SGHT|OBIO (Orchestra BioMed, Inc.) - Total Debt to Capital|Anika (ANIK) - Total Debt to Capital Coefficient|Total Debt to Capital NSPR|Total Debt to Equity Ratio zhjmedical.com ZJYL|Total Debt to Capital VANI (Vivani Medical)|Total Debt to Capital Xtant Medical Holdings, Inc. XTNT|NMTC - Debt to Equity|MODD: Debt to Equity|MYO (Myomo, Inc) - Total Debt to Equity Ratio|Envoy Medical Inc - All Debt to Shareholders' Equity Ratio|VVOS (Vivos Therapeutics) - Total Debt to Capital|Debt to Capital envveno.com NVNO|Debt to Equity Sintx Technologies (SINT)|Tenon Medical Inc. (TNON) - Debt to Capital Ratio|ReWalk Robotics Ltd - Total Debt to Equity Ratio|Total Debt to Capital Autonomix Medical Inc. AMIX|INVO Fertility Inc - Total Debt to Capital|Total Debt to Capital Coefficient bonebiologics.com BBLG|Axonics (AXNX) - Debt to Equity|Aggregate Debt to Equity BIOL (BIOLASE Inc.)|Debt to Equity Dynatronics Corp|Total Debt to Equity Ratio Paragon 28 Corp (FNA)|Total Debt to Capital INVO